azacitidine has been researched along with Chronic Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Bourke, C; Cummings, NJ; Curtis, DJ; Das, TP; Fleming, SA; Ivey, A; Kliman, DS; North, D; O'Brien, ME; Patil, SS; Spencer, A; Swain, MI; Tan, JLC; Widjaja, JML | 1 |
| Najima, Y | 1 |
| Cadeddu, RP; Christopeit, M; Drusenheimer, N; Esseling, E; Germing, U; Haas, R; Holtick, U; Jäger, P; Klein, S; Kobbe, G; Kröger, N; Mikesch, JH; Rautenberg, C; Scheid, C; Schroeder, T; Stelljes, M; Trenschel, R | 1 |
| Athanasiou, I; Bayer, H; Berberich, B; Bruckner-Tuderman, L; Dengjel, J; Gretzmeier, C; Kiritsi, D; Kühl, T; Nyström, A; Rafei-Shamsabadi, DA; Thriene, K | 1 |
| Ahmed, I; Bishop, R; Craddock, C; Dignan, FL; Elhaneid, M; Hodgkinson, A; Jackson, A; Malladi, R; McIlroy, G; Moss, P; Nunnick, J; Protheroe, R; Siddique, S | 1 |
| Guo, QL; Huang, CS; Liu, C; Wang, Y; Yan, JQ; Zhu, XY; Zou, WY | 1 |
| Airoldi, I; Amadori, A; Banelli, B; Cocco, C; Di Carlo, E; Moserle, L; Pezzolo, A; Pistoia, V; Romani, M; Rossi, E; Sorrentino, C | 1 |
| Byrd, JC; Issa, JP | 1 |
| Odenike, O; Tefferi, A | 1 |
| Ahlquist, DA; Burgart, LJ; Harrington, JJ; Klatt, KK; Lesche, R; Lewin, J; Lofton-Day, C; Molina, JR; Osborn, NK; Zou, H | 1 |
| Ley, TJ; Macher, AM; Nienhuis, AW; Sands, JM | 1 |
3 review(s) available for azacitidine and Chronic Disease
| Article | Year |
|---|---|
Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS.
Topics: Azacitidine; Chronic Disease; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Recurrence; Transplantation, Homologous | 2023 |
Decitabine in chronic leukemias.
Topics: Azacitidine; Chronic Disease; Combined Modality Therapy; Decitabine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2005 |
Conventional and new treatment options for myelofibrosis with myeloid metaplasia.
Topics: Androgens; Angiogenesis Inhibitors; Antineoplastic Agents; Azacitidine; Benzamides; Chronic Disease; Decitabine; Erythropoietin; Humans; Imatinib Mesylate; Piperazines; Primary Myelofibrosis; Pyrimidines; Quinolones; Recombinant Proteins | 2005 |
1 trial(s) available for azacitidine and Chronic Disease
| Article | Year |
|---|---|
Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial.
Topics: Azacitidine; Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Prospective Studies; Quality of Life; Steroids | 2021 |
7 other study(ies) available for azacitidine and Chronic Disease
| Article | Year |
|---|---|
Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Topics: Antigens, CD34; Azacitidine; Chimerism; Chronic Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Nuclear Proteins; Recurrence | 2023 |
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Topics: Adult; Azacitidine; Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Lymphocyte Transfusion; Myelodysplastic Syndromes; Recurrence; T-Lymphocytes; Transplantation, Homologous | 2023 |
Proteomic Profiling of Fibroblasts Isolated from Chronic Wounds Identifies Disease-Relevant Signaling Pathways.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Movement; Cell Proliferation; Chronic Disease; Female; Fibroblasts; Humans; Male; Middle Aged; Proteomics; Signal Transduction; Skin; Transforming Growth Factor beta; Wounds and Injuries | 2020 |
Intrathecal 5-azacytidine inhibits global DNA methylation and methyl- CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury.
Topics: Analysis of Variance; Animals; Azacitidine; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Functional Laterality; Gene Expression Regulation; Injections, Spinal; Male; Methyl-CpG-Binding Protein 2; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 2011 |
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.
Topics: Animals; Azacitidine; B-Lymphocytes; Chronic Disease; Decitabine; DNA Modification Methylases; Genes, Tumor Suppressor; Humans; Interleukin-12; Leukemia, B-Cell; Lymphoproliferative Disorders; Mice; Mice, Inbred NOD; Mice, SCID; Palatine Tonsil; Receptors, Interleukin; Receptors, Interleukin-12 | 2004 |
Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia.
Topics: Azacitidine; Biomarkers; Cell Line; Chronic Disease; Colitis, Ulcerative; Colonic Neoplasms; Colonic Polyps; Decitabine; Humans; Hydroxamic Acids; Methylation; Polymerase Chain Reaction; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trans-Activators | 2006 |
Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalassemia. Case report and review of the literature.
Topics: Adult; Azacitidine; Chronic Disease; Diagnosis, Differential; Entomophthora; Hematopoiesis; Humans; Immune Tolerance; Male; Mucormycosis; Mycoses; Splenectomy; Thalassemia | 1985 |